We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Kangaroo DNA May Provides Insights for Skin Cancer Prevention

By LabMedica International staff writers
Posted on 15 Jan 2010
Understanding how kangaroos repair their DNA could be the key to preventing skin cancer in the future, according to new research.

Dr. More...
Linda Feketeová and Dr. Uta Wille from the ARC Center of Excellence for Free Radical Chemistry and Biotechnology at the University of Melbourne (Australia), together with scientists from the University of Innsbruck (Austria), Dr. Feketeová and Dr. Wille, are working toward reducing the number of skin cancer-related cases by studying the chemistry behind potential skin cancer therapies. The teams are investigating a DNA repair enzyme found in kangaroos and many other organisms, but not humans. This enzyme is very effective in repairing a specific type of DNA damage linked to many skin cancers.

"As summer approaches, excessive exposure to the sun's harmful UV [ultraviolet] light will see more than 400,000 Australians diagnosed with skin cancer,” remarked Dr. Feketeová. "Other research teams have proposed a ‘dream cream' containing the DNA repair enzyme which you could slap on your skin after a day in the sun. We are now examining whether this would be feasible by looking at the chemistry behind the DNA repair system.”

Using highly advanced technology, the groups are simulating the skin's UV exposure in the laboratory, and then analyzing the DNA repair process in a specialized mass spectrometer instrument. "We were quite surprised that the DNA's repair process also resulted in a number of chemical by-products, which have never been seen before,” stated Dr. Wille. "Our plan is to study these products to understand if the DNA repair enzyme could be incorporated into a safe and effective method for skin cancer prevention.”

"But there is still much to investigate before this ‘dream cream' will be available at the pharmacy, so don't throw out your sunscreen just yet,” added Dr. Feketeová.

This work will be published as a "hot paper” in the upcoming edition of the journal Chemical Communications.

Related Links:
ARC Centre of Excellence for Free Radical Chemistry and Biotechnology
University of Innsbruck


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.